Estradiol Etodolac Famciclovir Fentanyl Filgrastim Finasteride Fiorinal Flunitrazepam Fluocinonide Fluconazole Fluoxetine Fluvoxamine Fremanezumab Gabapentin Galzin Haloperidol Haloperidol Decanoate Hydroxychloroquine Hydroxyzine Hydrochloride Ibuprofen Max Idarubicin HCl Ifosfamide Irinotecan Gianvi Irbesartan Junel Kariva Kelnor Lamotrigine Laquinimod Letrozole Leucovorin Calcium Levonorgestrel branded as Enpresse Loperamide 2mg Losartan Lorazepam Methotrexate Methylphenidate Minocycline Mirtazapine Mitoxantrone Montelukast (generic) Naltrexone Naloxone Naproxen Norepinephrine Norethisterone Nortrel Nortriptyline Nuvigil Nystatin Ocella Olanzapine Omeprazole Optalgin Oxycodone Oxymorphone Pantoprazole Phentermine Portia Pravastatin Pregabalin Prednisolone ProAir Provigil Quetiapine QVAR QNASL Ramipril Rasagiline Salbutamol (Albuterol) Sildenafil Sertraline Simvastatin Sprintec Sulfamethoxazole Trimethoprim Sumatriptan Tadalafil Tamoxifen Temazepam Temozolomide Tenofovir Terbinafin Testosterone Tiagabine Topiramate Tramadol Trazodone Triethylenetetramine Tri-Sprintec Ursodiol Valsartan Verapamil Velivet Venlafaxine Warfarin Zolpidem Zonisamide Zopiclone Recalls In 2018, Teva Pharmaceuticals USA recalled tablets containing valsartan due to the detection of N-nitrosodiethylamine (NDEA) which is a probable human carcinogen. See also BioTime Economy of Israel Health care in Israel Opioid epidemic in the United States Science and technology in Israel Teva Active Pharmaceutical Ingredients (TAPI) References External links Official website Companies listed on the Tel Aviv Stock Exchange Pharmaceutical companies of Israel Pharmaceutical companies established in 1901 Generic drug manufacturers Israeli brands Life sciences industry Companies based in Tel Aviv Multinational companies headquartered in Israel Social problems in medicine Pharmaceutical companies based in New Jersey